Nothing Special   »   [go: up one dir, main page]

Ito et al., 2011 - Google Patents

HCV Infection and B‐Cell Lymphomagenesis

Ito et al., 2011

View PDF @Full View
Document ID
11487196250096157229
Author
Ito M
Kusunoki H
Mochida K
Yamaguchi K
Mizuochi T
Publication year
Publication venue
Advances in hematology

External Links

Snippet

Hepatitis C virus (HCV) has been recognized as a major cause of chronic liver diseases worldwide. It has been suggested that HCV infects not only hepatocytes but also mononuclear lymphocytes including B cells that express the CD81 molecule, a putative HCV …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Zignego et al. HCV and lymphoproliferation
Breiman et al. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKε
Machida et al. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6
Taya et al. Fas‐mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C
Yamamoto et al. Lipoprotein receptors redundantly participate in entry of hepatitis C virus
Shrivastava et al. Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages
Wang et al. Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells
Das et al. TIM1 (HAVCR1) is not essential for cellular entry of either quasi-enveloped or naked hepatitis A virions
Her et al. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response
Vallat et al. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection
Yang et al. Involvement of DNA damage response pathways in hepatocellular carcinoma
Chang et al. Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture
Gastaminza et al. Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection
Howell et al. T oll‐like receptors in hepatitis C infection: Implications for pathogenesis and treatment
Zhang et al. HCV RNA activates APCs via TLR7/TLR8 while virus selectively stimulates macrophages without inducing antiviral responses
Imran et al. Interaction of Hepatitis C virus proteins with pattern recognition receptors
Fukasawa et al. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model
Bankwitz et al. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins
Xue et al. ISG12a restricts hepatitis C virus infection through the ubiquitination-dependent degradation pathway
Kaukinen et al. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression
Eksioglu et al. Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells
Forghieri et al. Pathogenetic mechanisms of hepatitis C virus‐induced B‐Cell lymphomagenesis
Upadya et al. Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases
Wallace et al. Crosstalk between pyroptosis and apoptosis in hepatitis C virus-induced cell death
Ray et al. Transforming growth factor beta in hepatitis C virus infection: in vivo and in vitro findings